Myocardial Protection Using Fructose-1,6-Diphosphate during Coronary Artery Bypass Graft Surgery: A Randomized, Placebo-Controlled Clinical Trial

Anesthesia and Analgesia

Volumn 98, Issue 1, 2004, Pages 20-29

  Riedel, Bernhard J ^a,d   Gal, Janos ^a   Ellis, Gillian ^b,c   Marangos, Paul J ^b,c   Fox, Anthony W ^b,c   Royston, David ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b Cypros Pharmaceutical Corporation   (United States)

^c Questcor Pharmaceuticals Inc   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; CORDOX; CPC 111; CREATINE KINASE MB; DRUG ADDITIVE; FRUCTOSE 1,6 BISPHOSPHATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOPLEGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEART FUNCTION; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE STROKE WORK INDEX; HEART PROTECTION; HEART WORK; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 0347363670     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000094336.97693.90     Document Type: Article

References (40)

1. Klatte K, Chaitman BR, Theroux P, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol 2001;38:1070-7.
2. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
3. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
4. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998;98:2227-34.
5. Markov AK, Oglethorpe NC, Young DB, Hellems HK. Irreversible hemorrhagic shock: treatment and cardiac pathophysiology. Circ Shock 1981;8:9-19.
6. Zhang JN, Zhang FM, Ma WS, Forrester T. Protective effect of exogenous fructose-1, 6-diphosphate in cardiogenic shock. Cardiovasc Res 1988;22:927-32.
7. Lazzarino G, Nuutinen ME, Tavazzi B, et al. Preserving effect of fructose-1, 6-bisphosphate on high-energy phosphate compounds during anoxia and reperfusion in isolated Langendorff-perfused rat hearts. J Mol Cell Cardiol 1991;23:13-23.
8. Cargnoni A, Condorelli E, Boraso A, et al. Role of timing of administration in the cardioprotective effect of fructose-1, 6-bisphosphate. Cardiovasc Drugs Ther 1992;6:209-17.
9. Takeuchi K, Cao-Danh H, Friehs I, et al. Administration of fructose 1, 6-diphosphate during early reperfusion significantly improves recovery of contractile function in the postischemic heart. J Thorac Cardiovasc Surg 1998;116:335-43.
10. Galzigna L, Rizzoli V, Bianchi M, et al. Some effects of fructose-1, 6-diphosphate on rat myocardial tissue related to a membrane-stabilizing action. Cell Biochem Funct 1989;7:91-6.
11. Rizzoli V, Battilana G, Galzigna L. Fructose-1, 6-diphosphate counteracts ethanol-stimulated calcium uptake in isolated BHK cells. Mol Cell Biochem 1990;95:89-93.
12. Xu KY, Zweier JL, Becker LC. Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 1995;77:88-97.
13. Akimitsu T, White JA, Carden DL, et al. Fructose-1, 6-diphosphate or adenosine attenuate leukocyte adherence in postischemic skeletal muscle. Am J Physiol 1995;269:H1743-51.
14. Cavallini L, Deana R, Francesconi MA, Alexandre A. Fructose-1, 6-diphosphate inhibits platelet activation. Biochem Pharmacol 1992;43:1539-44.
15. Schinetti ML, Lazzarino G. Inhibition of phorbol ester-stimulated chemiluminescence and superoxide production in human neutrophils by fructose 1, 6-diphosphate. Biochem Pharmacol 1986;35:1762-4.
16. Markov AK, Oglethorpe NC, Blake TM, et al. Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am Heart J 1980;100:639-46.
17. Tavazzi B, Cerroni L, Di Pierro D, et al. Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1, 6-bisphosphate. Free Radic Res Commun 1990;10:167-76.
18. Chien S, Zhang F, Niu W, et al. Fructose-1, 6-diphosphate and a glucose-free solution enhances functional recovery in hypothermic heart preservation. J Heart Lung Transplant 2000;19:277-85.
19. Farias LA, Willis M, Gregory GA. Effects of fructose-1, 6-diphosphate, glucose, and saline on cardiac resuscitation. Anesthesiology 1986;65:595-601.
20. Trimarchi GR, De Luca R, Campo GM, et al. Protective effects of fructose-1, 6-bisphosphate on survival and brain putrescine levels during ischemia and recirculation in the Mongolian gerbil. Stroke 1990;21:IV171-3.
21. Didlake R, Kirchner KA, Lewin J, et al. Attenuation of ischemic renal injury with fructose 1, 6-diphosphate. J Surg Res 1989;47:220-6.
22. Sun JX, Farias LA, Markov AK. Fructose 1-6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology 1990;98:117-26.
23. Merli M, Bergui G, Cattani C, et al. Recovery of post-arrest cardiac performance: effect of fructose-1, 6-diphosphate in the isolated rabbit heart. Riv Eur Sci Med Farmacol 1989;11:175-82.
24. Janz TG, Leasure J, Olson JE. The effects of fructose-1, 6-diphosphate on myocardial damage in acute coronary artery occlusion. Resuscitation 1991;22:45-54.
25. Webb WR. Metabolic effects of fructose diphosphate in hypoxic and ischemic states. J Thorac Cardiovasc Surg 1984;88:863-6.
26. Marchionni N, Conti A, De Alfieri W, et al. Hemodynamic and electrocardiographic effects of fructose-1, 6-diphosphate in acute myocardial infarction. Am J Cardiol 1985;56:266-9.
27. Grandi AM, Muggia C, Barzizza F, et al. Improved left ventricular function after short-term treatment with fructose-1, 6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy. Clin Ther 1988;10:372-80.
28. Munger MA, Botti RE, Grinblatt MA, Kasmer RJ. Effect of intravenous fructose-1, 6-diphosphate on myocardial contractility in patients with left ventricular dysfunction. Pharmacotherapy 1994;14:522-8.
29. Markov AK, Brumley MA, Figueroa A, et al. Hemodynamic effects of fructose 1, 6-diphosphate in patients with normal and impaired left ventricular function. Am Heart J 1997;133:541-9.
30. Nunes FB, Gaspareto PB, Santos RC, et al. Intravenous toxicity of fructose-1, 6-bisphosphate in rats. Toxicol Lett 2003;143:73-81.
31. Ehringer WD, Niu W, Chiang B, et al. Membrane permeability of fructose-1, 6-diphosphate in lipid vesicles and endothelial cells. Mol Cell Biochem 2000;210:35-45.
32. Hardin CD, Lazzarino G, Tavazzi B, et al. Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter. Am J Physiol Heart Circ Physiol 2001;281: H2654-60.
33. Cattani L, Costrini R, Lazzarino G, et al. Fructose-1, 6-diphosphate counteracts potassium effects on cardiac muscle. Pharmacol Res Commun 1984;16:785-93.
34. Markov AK, Payment MF, Hume AS, et al. Fructose-1, 6-diphosphate in the treatment of oleander toxicity in dogs. Vet Hum Toxicol 1999;41:9-15.
35. Sugiyama S, Satoh H, Nomura N, et al. The importance of glycolytically-derived ATP for the Na+/H+ exchange activity in guinea pig ventricular myocytes. Mol Cell Biochem 2001;217:153-61.
36. Morikawa S, Inubushi T, Takahashi K, et al. Dissociation between lactate accumulation and acidosis in middle cerebral artery-occluded rats assessed by 31P and 1H NMR metabolic images under a 2-T magnetic field. Magn Reson Imaging 1996;14:1197-204.
37. Cheng DC, Chung F, Burns RJ, et al. Postoperative myocardial infarction documented by technetium pyrophosphate scan using single-photon emission computed tomography: significance of intraoperative myocardial ischemia and hemodynamic control. Anesthesiology 1989;71:818-26.
38. Alyanakian MA, Dehoux M, Chatel D, et al. Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. J Cardiothorac Vasc Anesth 1998;12:288-94.
39. Jain U, Laflamme CJ, Aggarwal A, et al. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (Mc-SPI) Research Group Anesthesiology 1997;86:576-91.
40. King LM, Opie LH. Glucose and glycogen utilisation in myocardial ischemia: changes in metabolism and consequences for the myocyte. Mol Cell Biochem 1998;180:3-26.